Mark Velleca, StrideBio CEO

Gink­go snaps up gene ther­a­py vec­tor as­sets from Stride­Bio

Gink­go Bioworks is pick­ing up some vi­ral vec­tors, part of what it calls an on­go­ing push in­to gene ther­a­py ser­vices.

On Wednes­day, Gink­go an­nounced that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.